Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about BLOOD-BRAIN BARRIER DISRUPTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | BLOOD-BRAIN BARRIER DISRUPTION |
| Key Genes/Proteins | FUS, MFSD2A, VEGF |
| Related Diseases | NEUROINFLAMMATION, STROKE |
| Related Pathways | AMPK PATHWAY |
graph TD
BLOOD_BRAIN_BARRIER_DISRUPTION["BLOOD-BRAIN BARRIER DISRUPTION"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"causes"| Neuroinflammation["Neuroinflammation"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"contributes to"| Multiple_Sclerosis["Multiple Sclerosis"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"causes"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"causes"| Central_Nervous_System_Damage["Central Nervous System Damage"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"causes"| Cognitive_Impairment["Cognitive Impairment"]
BLOOD_BRAIN_BARRIER_DISRUPTION -->|"contributes to"| Neurodegenerative_Diseases["Neurodegenerative Diseases"]
TREM1["TREM1"] -->|"mediates"| BLOOD_BRAIN_BARRIER_DISRUPTION
Sepsis["Sepsis"] -->|"causes"| BLOOD_BRAIN_BARRIER_DISRUPTION
Ischemic_Stroke["Ischemic Stroke"] -->|"causes"| BLOOD_BRAIN_BARRIER_DISRUPTION
Tight_Junctions["Tight Junctions"] -->|"involved_in"| BLOOD_BRAIN_BARRIER_DISRUPTION
Methamphetamine["Methamphetamine"] -->|"causes"| BLOOD_BRAIN_BARRIER_DISRUPTION
Stroke["Stroke"] -->|"causes"| BLOOD_BRAIN_BARRIER_DISRUPTION
TREM1_Inhibition["TREM1 Inhibition"] -.protects against.-> BLOOD_BRAIN_BARRIER_DISRUPTION
Hypoxia["Hypoxia"] -->|"causes"| BLOOD_BRAIN_BARRIER_DISRUPTION| Target | Relation | Type | Str |
|---|---|---|---|
| Brain Arteriovenous Malformations | associated_with | disease | 0.95 |
| Increased Permeability | causes | phenotype | 0.95 |
| Long COVID-Associated Brain Fog | causes | disease | 0.95 |
| Neuroinflammation | causes | process | 0.92 |
| Stroke | contributes_to | disease | 0.91 |
| Neuroinflammation | mediates | process | 0.90 |
| Central Nervous System Diseases | contributes_to | disease | 0.90 |
| NEUROINFLAMMATION | causes | process | 0.90 |
| Multiple Sclerosis | associated_with | disease | 0.90 |
| Alzheimer's Disease | associated_with | disease | 0.90 |
| Chronic Inflammation | contributes_to | process | 0.90 |
| Traumatic Brain Injury | associated_with | disease | 0.90 |
| Central Nervous System Damage | causes | disease | 0.85 |
| Brain Hemorrhage | causes | disease | 0.85 |
| Neurodegenerative Diseases | contributes_to | disease | 0.85 |
| Neurological Sequelae | contributes_to | phenotype | 0.85 |
| Neurodegenerative Diseases | biomarker_for | disease | 0.85 |
| Glymphatic Dysfunction | exacerbates | mechanism | 0.85 |
| Cognitive Impairment | causes | phenotype | 0.85 |
| Neuroinflammation | associated_with | process | 0.85 |
| Brain Injury | contributes_to | process | 0.85 |
| neurodegeneration | promotes | phenotype | 0.85 |
| Neuroinflammatory Cascades | contributes_to | process | 0.85 |
| Brain Hemorrhage | contributes_to | disease | 0.80 |
| Bleeding Risk | contributes_to | phenotype | 0.80 |
| neuroinflammation | promotes | process | 0.80 |
| Parkinson's Disease | contributes_to | disease | 0.80 |
| Alzheimer's Disease | contributes_to | disease | 0.75 |
| NEUROINFLAMMATION | inhibits | phenotype | 0.65 |
| ENDOTHELIAL CELLS | regulates | cell_type | 0.65 |
| AMPK PATHWAY | associated_with | pathway | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| PREFRONTAL CORTEX | associated_with | brain_region | 0.45 |
| CORTEX | associated_with | brain_region | 0.45 |
| WHITE MATTER | associated_with | brain_region | 0.45 |
| EMPAGLIFLOZIN | associated_with | drug | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Ischemic Stroke | causes | disease | 0.95 |
| Sepsis | causes | disease | 0.95 |
| M2 Microglia-Targeting Lipid Nanoparticle | treats | drug | 0.90 |
| Tight Junction Damage | contributes_to | mechanism | 0.90 |
| Stroke | causes | disease | 0.90 |
| Tight Junctions | involved_in | process | 0.90 |
| Methamphetamine | causes | drug | 0.90 |
| Hypoxia | causes | process | 0.90 |
| TIGHT JUNCTION PROTEINS | mediates | protein | 0.90 |
| 35361905 | is a hallmark of | paper | 0.90 |
| AQP4 Autoantibodies | causes | biomarker | 0.90 |
| Sustained Systemic Inflammation | contributes_to | process | 0.90 |
| 33381913 | results in | paper | 0.90 |
| MICROGLIA | regulates | cell_type | 0.90 |
| TREM1 Inhibition | protects_against | mechanism | 0.90 |
| A1AR Ablation | protects_against | mechanism | 0.90 |
| CAV1 | contributes_to | protein | 0.87 |
| Autophagy Inhibition | associated_with | process | 0.87 |
| CLDN5 | involved_in | gene | 0.85 |
| CD40L | mediates | protein | 0.85 |
| APOE | involved_in | protein | 0.85 |
| Microglia Polarization | modulates | process | 0.85 |
| M2 Microglia | protects_against | cell_type | 0.85 |
| Tight Junction Damage | causes | mechanism | 0.85 |
| Complement System | promotes | pathway | 0.85 |
| EXTRACELLULAR HMGB1 | causes | protein | 0.85 |
| Complement System | contributes_to | pathway | 0.85 |
| tight junctions | contributes_to | process | 0.85 |
| APOE | contributes_to | protein | 0.82 |
| mRNA nanoparticles | ameliorates | compound | 0.80 |
| CLDN5 | biomarker_for | protein | 0.80 |
| AQP4 | associated_with | protein | 0.80 |
| COVID-19 | causes | disease | 0.80 |
| ZFPs | promotes | protein | 0.80 |
| ASPARAGINE ENDOPEPTIDASE | involved_in | enzyme | 0.75 |
| neuroinflammation | activates | process | 0.70 |
| APOE4 | causes | gene | 0.70 |
| EMPAGLIFLOZIN | inhibits | drug | 0.65 |
| MFSD2A | inhibits | gene | 0.65 |
| MICROGLIA | treats | cell_type | 0.65 |
| STROKE | treats | disease | 0.65 |
| VEGF | regulates | gene | 0.65 |
| ASTROCYTE | interacts_with | cell_type | 0.65 |
| STROKE | inhibits | disease | 0.65 |
| FUS | regulates | gene | 0.65 |
| AMPK | protects_against | protein | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Blood-Brain Barrier Disruption Enabling Peripheral Inflammat | 0.430 | neurodegeneration | How does APOE4 mechanistically increase |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.580
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning BLOOD-BRAIN BARRIER DISRUPTION in their description or question text
No additional research found